Last reviewed · How we verify
Varenicline Tartrate Nasal Spray — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Varenicline Tartrate Nasal Spray (Varenicline Tartrate Nasal Spray) — Corxel Pharmaceuticals.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Varenicline Tartrate Nasal Spray TARGET | Varenicline Tartrate Nasal Spray | Corxel Pharmaceuticals | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Varenicline Tartrate Nasal Spray CI watch — RSS
- Varenicline Tartrate Nasal Spray CI watch — Atom
- Varenicline Tartrate Nasal Spray CI watch — JSON
- Varenicline Tartrate Nasal Spray alone — RSS
Cite this brief
Drug Landscape (2026). Varenicline Tartrate Nasal Spray — Competitive Intelligence Brief. https://druglandscape.com/ci/varenicline-tartrate-nasal-spray. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab